GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Balsm Alofoq Medical Company CJSC 9620.SR · SAR

Health Care · Tadawul · 🇸🇦 Saudi Arabia

Compare

22.00

—

Close of 28 Oct 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Balsm Alofoq Medical Company CJSC

Its shares trade on Tadawul under the ticker 9620.SR. It has been listed since 16 December 2024. In the fiscal year to 31 December 2025, it reported revenue of SAR 20.4m and net income of SAR 2.0m. At that date it held total assets of SAR 35.6m and shareholders' equity of SAR 30.9m.

Balsm Alofoq Medical Co. engages in the provision of healthcare supplies and services. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2024-12-16. The firm is engaged in the operation of hospitals, specialized medical complexes, general medical complexes, medical clinics, medical operation of medical complexes, day surgery centers, medical laboratories, wholesale of medical devices, equipment, and supplies, retail of medical devices, equipment, and supplies, medical equipment and product warehouses, social welfare institutions, identification and distribution of social assistance, daycare for people with special needs, adoption services, and counselling for families and individuals.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
16 Dec 2024

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Riyadh, Saudi Arabia, providing healthcare supplies and services.
  • Offers a wide range of healthcare services including hospitals, clinics, and medical laboratories.
  • Engaged in both wholesale and retail of medical devices, equipment, and supplies.

Weaknesses

  • IPO scheduled for December 16, 2024, indicating limited historical market presence.
  • No specific financial data or performance metrics provided in the source.
  • Operational details of social welfare institutions and adoption services are not clearly defined.

Opportunities

  • Expanding healthcare infrastructure in Saudi Arabia presents growth potential.
  • Increasing demand for medical services and supplies in the region.
  • Potential for IPO to attract investment and scale operations.

Threats

  • Competition from established healthcare providers in Saudi Arabia.
  • Regulatory challenges in the healthcare sector may impact operations.
  • Dependence on the Saudi healthcare market for revenue generation.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.